Caseína quinase
As caseína quinases são uma família de proteínas quinases serina/treonina que regulam vários processos celulares, incluindo a reparação do DNA, os ritmos circadianos e a transdução de sinais. Essas quinases estão envolvidas na fosforilação de numerosas proteínas e estão implicadas em doenças como o câncer, distúrbios neurodegenerativos e síndromes metabólicas. Na CymitQuimica, oferecemos uma seleção de inibidores de caseína quinase para apoiar sua pesquisa em transdução de sinais, regulação do ciclo celular e desenvolvimento terapêutico.
Foram encontrados 130 produtos de "Caseína quinase"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Silmitasertib
CAS:<p>Silmitasertib (CX-4945) is a potent, orally bioavailable inhibitor of casein kinase 2 (CK2; Ki: 0.38 nM).</p>Fórmula:C19H12ClN3O2Pureza:98% - 99.90%Cor e Forma:SolidPeso molecular:349.77PF-670462
CAS:<p>PF-670462 is a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 additional kinases) inhibitor of CK1ε in isolated enzyme preparations.</p>Fórmula:C19H22Cl2FN5Pureza:99.42% - 99.72%Cor e Forma:SolidPeso molecular:410.32XL413
CAS:<p>XL-413 is an oral CDC7 kinase inhibitor, potentially blocking DNA replication, mitosis, and cancer cell growth.</p>Fórmula:C14H12ClN3O2Pureza:98.40% - >99.99%Cor e Forma:SolidPeso molecular:289.72SSTC3
CAS:<p>SSTC3 is a casein kinase 1α (CK1α) activator with potential antitumor activity that inhibits WNT signaling.</p>Fórmula:C23H17F3N4O3S2Pureza:98.65% - 99.94%Cor e Forma:SolidPeso molecular:518.53AMG-548
CAS:<p>AMG-548, oral p38α inhibitor (Ki=0.5 nM), >1000x selectivity over p38γ/δ, blocks TNFα (IC50=3 nM), also inhibits Wnt/Casein kinase 1δ/ε.</p>Fórmula:C29H27N5OPureza:99.91%Cor e Forma:SolidPeso molecular:461.56SR-1277
CAS:<p>SR-1277 is a potent, highly selective and ATP-competitive CK1δ/ε inhibitor, regulating Wee1 activity at the G2/M cell-cycle interface, and antiproliferative.</p>Fórmula:C21H19N9O3SCor e Forma:SolidPeso molecular:477.5CK2/PIM1-IN-1
CAS:<p>CK2/PIM1-IN-1 inhibits CK2 & PIM1 (IC50s: 3.787 & 4.327 μM), aimed for cancer research.</p>Fórmula:C15H9NO4S2Pureza:98%Cor e Forma:SolidPeso molecular:331.374,5,6,7-Tetrabromobenzimidazole
CAS:<p>4,5,6,7-Tetrabromobenzimidazole is a selective and ATP-competitive inhibitor of protein kinase CK2 [1].</p>Fórmula:C7H2Br4N2Cor e Forma:SolidPeso molecular:433.72CK2-IN-9
CAS:<p>CK2-IN-9, a potent and selective CK2 kinase inhibitor, exhibits an inhibitory concentration (IC50) of 3 nM against its target enzyme and hampers Wnt reporter</p>Fórmula:C23H29N9OCor e Forma:SolidPeso molecular:447.54Quinalizarin
CAS:<p>Quinalizarin, the most selective CK2 inhibitor, is superior to CX-4945 which is the first-in-class CK2 inhibitor.</p>Fórmula:C14H8O6Pureza:98%Cor e Forma:SolidPeso molecular:272.21Tyrphostin AG 1112
CAS:<p>Tyrphostin AG 1112 is a Bcr-Abl kinase blocker. It can activate the terminal differentiation of K562 cells and the purging of Ph+ cells.</p>Fórmula:C15H10N6Cor e Forma:SolidPeso molecular:274.28PF 4800567 hydrochloride
CAS:<p>casein kinase 1ε inhibitor</p>Fórmula:C17H19Cl2N5O2Pureza:98%Cor e Forma:SolidPeso molecular:396.27IQA
CAS:<p>IQA is a casein kinase 2 (CK2) inhibitor.</p>Fórmula:C17H12N2O3Cor e Forma:SolidPeso molecular:292.29(R)-DRF053 dihydrochloride
CAS:<p>cdk/CK1 inhibitor,potent and ATP-competitive</p>Fórmula:C23H29Cl2N7OPureza:98%Cor e Forma:SolidPeso molecular:490.43TMCB
CAS:<p>CK2 and ERK8 inhibitor</p>Fórmula:C11H9Br4N3O2Pureza:98%Cor e Forma:SolidPeso molecular:534.82CK2-IN-6
CAS:<p>CK2-IN-6: Potent CK2 inhibitor for cancer, inflammation, pain, and immune research.</p>Fórmula:C19H16ClN7O2Cor e Forma:SolidPeso molecular:409.83SRPIN-803
CAS:<p>SRPIN-803 is a selective dual SRPK1 and CK2 inhibitor.</p>Fórmula:C14H9F3N4O3SPureza:98%Cor e Forma:SolidPeso molecular:370.31Umbralisib sulfate
CAS:<p>Umbralisib sulfate, an oral dual PI3Kδ/CK1ε inhibitor (EC50: 22.2 nM/6.0 μM), targets CLL T cells for blood cancer research.</p>Fórmula:C31H26F3N5O7SCor e Forma:SolidPeso molecular:669.63Umbralisib tosylate
CAS:<p>Umbralisib tosylate, an oral PI3Kδ/CK1ε inhibitor (EC50: 22.2 nM/6.0 μM), shows promise for CLL research.</p>Fórmula:C38H32F3N5O6SCor e Forma:SolidPeso molecular:743.75BTX161
CAS:<p>BTX161: potent CKIα degrader, surpasses Lenalidomide in AML, triggers DDR + p53, stabilizes MDM2.</p>Fórmula:C15H16N2O3Cor e Forma:SolidPeso molecular:272.3
